Fanglei You
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 5
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- J. Dirk Iglehart (2 shared papers)Lyndsay N. Harris (2 shared papers)Paula N. Friedman (2 shared papers)Agnes Witkiewicz (1 shared paper)Steven E. Come (1 shared paper)Paula D. Ryan (1 shared paper)Dennis C. Sgroi (1 shared paper)Rebecca Gelman (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Annals of Plastic Surgery (1 paper)Journal of Surgical Research (1 paper)Journal of Hematology & Oncology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Fanglei You
9 papers receiving 288 citations
Peers
Comparison fields: 5 of 43
- Oncology 197
- Cancer Research 88
- Radiology, Nuclear Medicine and Imaging 94
- Dermatology 25
- Immunology and Allergy 15
Countries citing papers authored by Fanglei You
This map shows the geographic impact of Fanglei You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglei You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglei You more than expected).
Fields of papers citing papers by Fanglei You
This network shows the impact of papers produced by Fanglei You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglei You. The network helps show where Fanglei You may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanglei You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 190 | |
| 2 | 2014 | 33 | |
| 3 | 2008 | 28 | |
| 4 | 2021 | 25 | |
| 5 | 2004 | 14 | |
| 6 | 2013 | 8 | |
| 7 | 2020 | 2 | |
| 8 | 2015 | 1 | |
| 9 | 2021 | 1 |
About Fanglei You
Fanglei You is a scholar working on Oncology, Molecular Biology, Immunology, Dermatology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 302 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Dermatologic Treatments and Research (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Treatment and Pharmacology (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (197 citations), Cancer Research (88 citations), Radiology, Nuclear Medicine and Imaging (94 citations), Dermatology (25 citations) and Immunology and Allergy (15 citations). Fanglei You has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include J. Dirk Iglehart, Lyndsay N. Harris, Paula N. Friedman, Agnes Witkiewicz, Steven E. Come, Paula D. Ryan, Dennis C. Sgroi, Rebecca Gelman, Stuart J. Schnitt and Harold J. Burstein. Their work appears in journals such as Clinical Cancer Research, Annals of Plastic Surgery, Journal of Surgical Research, Journal of Hematology & Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.